ANIP- Ani Pharmaceuticals, Inc.

Name: Ani Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ani Pharmaceuticals, Inc. (ANIP) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. ANIP is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
COO	Shanmugam Muthusamy	431.9K	$35.84M	-
CEO	Lalwani Nikhil	411.2K	$34.12M	-
CFO	Carey Stephen P.	180.9K	$15.01M	-
VP	Gassert Chad	158.5K	$13.15M	-
Other	Mutz Christopher	91.3K	$7.58M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 13, 2026	Mutz Christopher45	Head Of Rare Disease	Sell	3,162	$71.64	$226,525.68	-3.3%	-	-
Mar 13, 2026	Cook Meredith50	Sr. VP, General Counsel &Sec.	Sell	500	$72.62	$36,310.00	-0.6%	-	-
Mar 11, 2026	Rowland Thomas Andrew	SVP, Head - Established Brands	Sell	4,772	$74.91	$357,470.52	-11.0%	-	-
Jan 13, 2026	Cook Meredith50	Sr. VP, General Counsel &Sec.	Sell	500	$84.33	$42,165.00	-0.7%	-4.8%	-
Dec 18, 2025	Davis Krista45	SVP, Chief Hr Officer	Sell	1,622	$82.40	$133,652.80	-2.7%	-10.5%	-
Dec 12, 2025	Cook Meredith50	Sr. VP, General Counsel &Sec.	Sell	400	$82.32	$32,928.00	-0.5%	-9.8%	-
Dec 5, 2025	Tannenbaum Renee P55	Director	Sell	1,800	$81.15	$146,070.00	-6.7%	-7.5%	-
Nov 13, 2025	Cook Meredith50	Sr. VP, General Counsel &Sec.	Sell	400	$87.27	$34,908.00	-0.5%	-9.8%	-
Nov 13, 2025	Walsh Patrick D52	Director	Sell	8,643	$86.88	$750,903.84	-12.3%	-9.8%	-
Nov 13, 2025	Gassert Chad60	SVP - Corp. Dev. &Strategy	Sell	14,736	$89.06	$1,312,434.94	-4.4%	-9.8%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC